We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

3 hedge funds and large institutions have $1.66K invested in Artelo Biosciences, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% less capital invested

Capital invested by funds: $1.9K → $1.66K (-$234)

40% less funds holding

Funds holding: 5 → 3 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$4
2
UBS Group
UBS Group
Switzerland
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$1.09K – – –
AGM
2
Alpine Global Management
New York
$563 – – –
Morgan Stanley
3
Morgan Stanley
New York
$12 +$5 +162 +100%
Bank of America
4
Bank of America
North Carolina
– -$4 -100 Closed
UBS Group
5
UBS Group
Switzerland
– -$4 -100 Closed

ARTLW Hedge Fund Activity: Q4 2023 in Review

3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q4 2023, worth a combined $1.66K — down 12% from $1.9K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ARTLW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $5. The largest seller was Bank of America, exiting entirely with an estimated $4 sold.

  • 3 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q4 2023, down from 5 in Q3 2023.
  • Funds reported $1.66K of Artelo Biosciences, Inc. Warrant stock for Q4 2023, down 12% quarter-over-quarter.
  • 0 funds opened new Artelo Biosciences, Inc. Warrant positions in Q4 2023 and 2 closed out, a net change of -2 holders.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q4 2023 was Morgan Stanley, an estimated $5 added.
  • The largest Artelo Biosciences, Inc. Warrant seller in Q4 2023 was Bank of America, an estimated $4 sold.

Based on aggregated 13F filings for Q4 2023.